Top Markets
Coin of the day
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
株式のランク #39100
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
株価
$0.02243487
最終同期: 2025-06-04
時価総額
$650.09K
変化(1日)
0.39%
変化(1年)
0.00%
SE
取引 Lipidor AB (publ) (LIPI)

カテゴリー

Lipidor AB (publ)(LIPI)の株式分割履歴
Lipidor AB (publ)株(シンボル:LIPI)は合計で1回の株式分割を実施しました。
最新の株式分割はMay 24, 2024に行われました。
May 24, 2024より前に購入されたLIPI株は、現在3.811LIPI株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
2024-05-24 3811:1000 x3.811 x3.811
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
4 x15
US
7 x432
US
0 -
US
2 x10000
CH
7 x226
US